- $1.75bn
- $2.01bn
- $445.00m
- 55
- 40
- 82
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 416 | 430 | 532 | 447 | 445 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 331 | 473 | 422 | 366 | 457 |
Operating Profit | 85 | -43.1 | 109 | 80.3 | -11.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 62.3 | -78.7 | 153 | 89.1 | -21.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 60 | -83.2 | 142 | 79.5 | -29.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 46.8 | 4.05 | 21.5 | 19.8 | 12.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 46.8 | 4.05 | 53.2 | 53 | 12.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.84 | 0.429 | 0.339 | 0.299 | 0.114 |
Dividends per Share |